MARKET

FLNA

FLNA

Filana Therapeutics
NASDAQ
1.440
-0.120
-7.69%
After Hours: 1.460 +0.02 +1.39% 16:29 04/29 EDT
OPEN
1.560
PREV CLOSE
1.560
HIGH
1.560
LOW
1.430
VOLUME
422.54K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
1.430
MARKET CAP
69.56M
P/E (TTM)
-0.7645
1D
5D
1M
3M
1Y
5Y
1D
Filana Therapeutics director Michael O'Donnell to resign after annual meeting
PUBT · 1d ago
Filana Therapeutics announces annual stockholders meeting webcast
PUBT · 1d ago
Weekly Report: what happened at FLNA last week (0420-0424)?
Weekly Report · 2d ago
Weekly Report: what happened at FLNA last week (0413-0417)?
Weekly Report · 04/20 09:35
Filana Therapeutics publishes simufilam preclinical data
TipRanks · 04/15 12:20
Filana publishes preclinical data showing simufilam slows seizure progression in TSC mice
PUBT · 04/15 12:04
Filana Therapeutics Announces Publication In Epilepsia Of Preclinical Data Showing Simufilam Attenuated Seizure Progression In Mouse Model Of Severe TSC-Related Epilepsy
Benzinga · 04/15 12:04
Weekly Report: what happened at FLNA last week (0406-0410)?
Weekly Report · 04/13 09:36
More
About FLNA
Filana Therapeutics, Inc., formerly Cassava Sciences, Inc., is a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Webull offers Filana Therapeutics Inc stock information, including NASDAQ: FLNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLNA stock methods without spending real money on the virtual paper trading platform.